To the extent that the effects of AgRP neuron inactivation reported herein translate to human diabetes, our finding that this intervention ameliorates hyperglycemia without apparent off-target effects identifies these neurons as potential therapeutic targets. This evidence concerns the gene AGRP and diabetes mellitus.